Cargando…
Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
BACKGROUND: Medulloblastoma is the most common type of malignant brain tumor that afflicts children. Although recent advances in chemotherapy and radiation have improved outcomes, high-risk patients do poorly with significant morbidity. METHODS: To identify new molecular targets, we performed an int...
Autores principales: | Harris, Peter S, Venkataraman, Sujatha, Alimova, Irina, Birks, Diane K, Balakrishnan, Ilango, Cristiano, Brian, Donson, Andrew M, Dubuc, Adrian M, Taylor, Michael D, Foreman, Nicholas K, Reigan, Philip, Vibhakar, Rajeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987923/ https://www.ncbi.nlm.nih.gov/pubmed/24661910 http://dx.doi.org/10.1186/1476-4598-13-72 |
Ejemplares similares
-
MPS1 kinase as a potential therapeutic target in medulloblastoma
por: Alimova, Irina, et al.
Publicado: (2016) -
Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells
por: Harris, Peter S, et al.
Publicado: (2012) -
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma
por: Prince, Eric W., et al.
Publicado: (2016) -
Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma
por: Venkataraman, Sujatha, et al.
Publicado: (2014) -
Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor
por: Alimova, Irina, et al.
Publicado: (2017)